vs
林德(LIN)与NATURAL HEALTH TRENDS CORP(NHTC)财务数据对比。点击上方公司名可切换其他公司
NATURAL HEALTH TRENDS CORP的季度营收约是林德的1.1倍($9.7M vs $8.8M),林德同比增速更快(8.2% vs -10.1%),林德自由现金流更多($898.0K vs $-964.0K),过去两年NATURAL HEALTH TRENDS CORP的营收复合增速更高(-5.6% vs -96.7%)
林德是全球知名跨国化工企业,按市场份额及营收计为全球最大工业气体供应商。公司1879年由德国科学家、工程师卡尔·冯·林德在德国威斯巴登创立,现总部位于英国沃金,在爱尔兰注册,2018年由原林德股份公司与1907年在美国成立的普莱克斯合并组建。
Sword Health是一家数字医疗企业,专注开发针对肌肉骨骼疾病、骨盆健康与损伤预防的物理治疗方案。该企业2015年由Virgílio Bento与Márcio Colunas在葡萄牙创立,将人工智能融入护理模式,提供数字化物理治疗服务。截至2024年,Sword Health已开展国际化运营,在美国、爱尔兰与葡萄牙均设有办公室。
LIN vs NHTC — 直观对比
营收规模更大
NHTC
是对方的1.1倍
$8.8M
营收增速更快
LIN
高出18.4%
-10.1%
自由现金流更多
LIN
多$1.9M
$-964.0K
两年增速更快
NHTC
近两年复合增速
-96.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.8M | $9.7M |
| 净利润 | — | $-588.0K |
| 毛利率 | 48.5% | 72.9% |
| 营业利润率 | 27.8% | -6.5% |
| 净利率 | — | -6.0% |
| 营收同比 | 8.2% | -10.1% |
| 净利润同比 | — | -434.1% |
| 每股收益(稀释后) | $3.98 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LIN
NHTC
| Q1 26 | $8.8M | — | ||
| Q4 25 | $8.8B | $9.7M | ||
| Q3 25 | $8.6B | $9.5M | ||
| Q2 25 | $8.5B | $9.8M | ||
| Q1 25 | $8.1B | $10.7M | ||
| Q4 24 | $8.3B | $10.8M | ||
| Q3 24 | $8.4B | $10.7M | ||
| Q2 24 | $8.3B | $10.5M |
净利润
LIN
NHTC
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $-588.0K | ||
| Q3 25 | $1.9B | $-431.0K | ||
| Q2 25 | $1.8B | $15.0K | ||
| Q1 25 | $1.7B | $122.0K | ||
| Q4 24 | $1.7B | $176.0K | ||
| Q3 24 | $1.6B | $35.0K | ||
| Q2 24 | $1.7B | $173.0K |
毛利率
LIN
NHTC
| Q1 26 | 48.5% | — | ||
| Q4 25 | — | 72.9% | ||
| Q3 25 | — | 73.7% | ||
| Q2 25 | — | 73.9% | ||
| Q1 25 | — | 73.6% | ||
| Q4 24 | — | 74.2% | ||
| Q3 24 | — | 74.1% | ||
| Q2 24 | — | 74.2% |
营业利润率
LIN
NHTC
| Q1 26 | 27.8% | — | ||
| Q4 25 | 23.0% | -6.5% | ||
| Q3 25 | 27.5% | -5.2% | ||
| Q2 25 | 27.7% | -3.4% | ||
| Q1 25 | 26.9% | -3.2% | ||
| Q4 24 | 27.4% | -3.9% | ||
| Q3 24 | 25.0% | -2.6% | ||
| Q2 24 | 26.4% | -2.3% |
净利率
LIN
NHTC
| Q1 26 | — | — | ||
| Q4 25 | 17.5% | -6.0% | ||
| Q3 25 | 22.4% | -4.5% | ||
| Q2 25 | 20.8% | 0.2% | ||
| Q1 25 | 20.6% | 1.1% | ||
| Q4 24 | 20.8% | 1.6% | ||
| Q3 24 | 18.5% | 0.3% | ||
| Q2 24 | 20.1% | 1.7% |
每股收益(稀释后)
LIN
NHTC
| Q1 26 | $3.98 | — | ||
| Q4 25 | $3.28 | $-0.05 | ||
| Q3 25 | $4.09 | $-0.04 | ||
| Q2 25 | $3.73 | $0.00 | ||
| Q1 25 | $3.51 | $0.01 | ||
| Q4 24 | $3.61 | $0.01 | ||
| Q3 24 | $3.22 | $0.00 | ||
| Q2 24 | $3.44 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $28.9M |
| 总债务越低越好 | $24.7M | — |
| 股东权益账面价值 | $40.1M | $23.4M |
| 总资产 | $86.3M | $38.4M |
| 负债/权益比越低杠杆越低 | 0.62× | — |
8季度趋势,按日历期对齐
现金及短期投资
LIN
NHTC
| Q1 26 | $4.0M | — | ||
| Q4 25 | $5.1B | $28.9M | ||
| Q3 25 | $4.5B | $32.0M | ||
| Q2 25 | $4.8B | $34.2M | ||
| Q1 25 | $5.3B | $41.9M | ||
| Q4 24 | $4.8B | $43.9M | ||
| Q3 24 | $5.2B | $46.3M | ||
| Q2 24 | $4.6B | $48.7M |
总债务
LIN
NHTC
| Q1 26 | $24.7M | — | ||
| Q4 25 | $20.7B | — | ||
| Q3 25 | $18.6B | — | ||
| Q2 25 | $19.7B | — | ||
| Q1 25 | $17.6B | — | ||
| Q4 24 | $15.3B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $16.9B | — |
股东权益
LIN
NHTC
| Q1 26 | $40.1M | — | ||
| Q4 25 | $38.2B | $23.4M | ||
| Q3 25 | $38.6B | $26.1M | ||
| Q2 25 | $38.5B | $28.9M | ||
| Q1 25 | $38.0B | $30.9M | ||
| Q4 24 | $38.1B | $32.9M | ||
| Q3 24 | $39.2B | $35.3M | ||
| Q2 24 | $38.2B | $37.3M |
总资产
LIN
NHTC
| Q1 26 | $86.3M | — | ||
| Q4 25 | $86.8B | $38.4M | ||
| Q3 25 | $86.0B | $42.3M | ||
| Q2 25 | $86.1B | $45.2M | ||
| Q1 25 | $82.7B | $53.2M | ||
| Q4 24 | $80.1B | $55.4M | ||
| Q3 24 | $82.5B | $58.3M | ||
| Q2 24 | $80.2B | $61.5M |
负债/权益比
LIN
NHTC
| Q1 26 | 0.62× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.44× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-959.0K |
| 自由现金流经营现金流 - 资本支出 | $898.0K | $-964.0K |
| 自由现金流率自由现金流/营收 | 10.2% | -9.9% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.2B | $-6.1M |
8季度趋势,按日历期对齐
经营现金流
LIN
NHTC
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $-959.0K | ||
| Q3 25 | $2.9B | $113.0K | ||
| Q2 25 | $2.2B | $-5.6M | ||
| Q1 25 | $2.2B | $484.0K | ||
| Q4 24 | $2.8B | $88.0K | ||
| Q3 24 | $2.7B | $-436.0K | ||
| Q2 24 | $1.9B | $-3.6M |
自由现金流
LIN
NHTC
| Q1 26 | $898.0K | — | ||
| Q4 25 | $1.6B | $-964.0K | ||
| Q3 25 | $1.7B | $70.0K | ||
| Q2 25 | $954.0M | $-5.6M | ||
| Q1 25 | $891.0M | $468.0K | ||
| Q4 24 | $1.6B | $68.0K | ||
| Q3 24 | $1.7B | $-443.0K | ||
| Q2 24 | $796.0M | $-3.6M |
自由现金流率
LIN
NHTC
| Q1 26 | 10.2% | — | ||
| Q4 25 | 17.9% | -9.9% | ||
| Q3 25 | 19.4% | 0.7% | ||
| Q2 25 | 11.2% | -57.5% | ||
| Q1 25 | 11.0% | 4.4% | ||
| Q4 24 | 18.8% | 0.6% | ||
| Q3 24 | 19.9% | -4.1% | ||
| Q2 24 | 9.6% | -34.2% |
资本支出强度
LIN
NHTC
| Q1 26 | — | — | ||
| Q4 25 | 16.6% | 0.1% | ||
| Q3 25 | 14.8% | 0.5% | ||
| Q2 25 | 14.8% | 0.0% | ||
| Q1 25 | 15.7% | 0.1% | ||
| Q4 24 | 15.1% | 0.2% | ||
| Q3 24 | 12.8% | 0.1% | ||
| Q2 24 | 13.7% | 0.2% |
现金转化率
LIN
NHTC
| Q1 26 | — | — | ||
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.25× | -375.67× | ||
| Q1 25 | 1.29× | 3.97× | ||
| Q4 24 | 1.63× | 0.50× | ||
| Q3 24 | 1.76× | -12.46× | ||
| Q2 24 | 1.16× | -20.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图